Oxetanes as versatile elements in drug discovery and synthesis

Angewandte Chemie
Johannes A BurkhardErick M Carreira


Sizable resources, both financial and human, are invested each year in the development of new pharmaceutical agents. However, despite improved techniques, the new compounds often encounter difficulties in satisfying and overcoming the numerous physicochemical and many pharmacological constraints and hurdles. Oxetanes have been shown to improve key properties when grafted onto molecular scaffolds. Of particular interest are oxetanes that are substituted only in the 3-position, since such units remain achiral and their introduction into a molecular scaffold does not create a new stereocenter. This Minireview gives an overview of the recent advances made in the preparation and use of 3-substituted oxetanes. It also includes a discussion of the site-dependent modifications of various physicochemical and biochemical properties that result from the incorporation of the oxetane unit in molecular architectures.


Apr 1, 1990·Medicinal Research Reviews·W J Greenlee
Nov 1, 1986·The Journal of Antibiotics·N ShimadaT Takita
Jul 1, 1987·The Journal of Antibiotics·H HoshinoT Takeuchi
Aug 27, 1971·Nature·G Holan
Sep 1, 1994·Bioorganic & Medicinal Chemistry·S H RosenbergH D Kleinert
Nov 26, 1999·Bioorganic & Medicinal Chemistry Letters·T C BogeG I Georg
May 18, 2000·The Journal of Organic Chemistry·M WangJ P Snyder
Sep 18, 2001·The Journal of Organic Chemistry·J W Bode, E M Carreira
Oct 25, 2001·The Journal of Organic Chemistry·A. A. Leslie GunatilakaErnest Hamel
Jan 10, 2002·Chemical Reviews·Yves DejaegherNorbert De Kimpe
Mar 7, 2002·Journal of the American Chemical Society·Vladimir B Birman, Samuel J Danishefsky
Oct 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·John LohGary Stacey
Jul 11, 2003·Bioorganic & Medicinal Chemistry Letters·Joseph L DuffyJames R Tata
Aug 1, 1959·Journal of Medicinal and Pharmaceutical Chemistry·H T GIER, S SEARLES
Feb 5, 2004·Journal of the American Chemical Society·Lars P C NielsenEric N Jacobsen
Mar 23, 2004·Organic & Biomolecular Chemistry·Joel L WolkShmaryahu Hoz
Aug 21, 2004·Planta medica·Quanbin HanHandong Sun
Dec 29, 2005·Angewandte Chemie·Goverdhan Mehta, S Robindro Singh
Oct 3, 2006·Angewandte Chemie·Georg WuitschikErick M Carreira
Apr 26, 2007·Anesthesia and Analgesia·Edmond I EgerYan Lou
Dec 11, 2007·Journal of the American Chemical Society·Wei HeAlison J Frontier
May 10, 2008·Angewandte Chemie·Georg WuitschikErick M Carreira
Jul 10, 2008·Organic Letters·Matthew A J DunctonMichael G Kelly
Jul 18, 2008·Organic Letters·Johannes Burkhard, Erick M Carreira
Jul 18, 2008·Organic & Biomolecular Chemistry·Anna K H HirschFrançois Diederich
Jul 21, 2009·The Journal of Organic Chemistry·Matthew A J DunctonMichael G Kelly

❮ Previous
Next ❯


Nov 11, 2011·Journal of the American Chemical Society·Kohsuke AikawaKoichi Mikami
Mar 19, 2011·Journal of Medicinal Chemistry·Nicholas A Meanwell
Oct 15, 2011·Journal of Medicinal Chemistry·Antonia F StepanR Scott Obach
Dec 19, 2013·Journal of Medicinal Chemistry·Tim H M JonckersPierre Raboisson
Jul 20, 2011·Organic Letters·Shogo HashizumeMotomu Kanai
Aug 13, 2011·Organic Letters·Kevin D BunkerPaul F Richardson
Oct 20, 2011·Organic Letters·Dong Bo LiErick M Carreira
Nov 25, 2011·Organic Letters·Johannes A BurkhardErick M Carreira
Oct 31, 2012·Organic Letters·Raúl Pérez-RuizMiguel A Miranda
Aug 14, 2013·Organic Letters·Johannes A BurkhardErick M Carreira
Aug 5, 2011·Chemical Communications : Chem Comm·Donato Ivan CoppiVito Capriati
Aug 13, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Michael GurryFawaz Aldabbagh
Feb 19, 2016·Organic Letters·Michael RalphKevin I Booker-Milburn
Feb 2, 2016·Organic Letters·Megan L JamiesonMargaret A Brimble
Aug 22, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Nathalie RiouxNigel J Waters
Sep 1, 2015·Journal of the American Chemical Society·Samuel J ThompsonGuangbin Dong
Aug 1, 2015·The Journal of Organic Chemistry·Christian A Malapit, Amy R Howell
May 10, 2016·Journal of the American Chemical Society·Cedric L Hugelshofer, Thomas Magauer
Jun 4, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xue-Qing LiLars Weidolf
Jul 8, 2016·Journal of the American Chemical Society·Marcin OdachowskiVarinder K Aggarwal
Sep 16, 2016·Chemical Reviews·James A BullKate F Morgan
Sep 24, 2016·The Journal of Organic Chemistry·Ahmad F KassirDavid J Aitken
May 2, 2017·Organic Letters·Guido P MöllerErick M Carreira
Apr 1, 2017·Organic & Biomolecular Chemistry·Damien Hazelard, Philippe Compain
Mar 7, 2017·Chemistry : a European Journal·Omar BoutureiraGonçalo J L Bernardes
Jun 7, 2017·Organic Letters·Jonathan D BeadleMichael Shipman
Sep 8, 2016·Chemistry : a European Journal·Cedric L Hugelshofer, Thomas Magauer
Aug 22, 2014·Chemical Reviews·Pankaj ChauhanDieter Enders
Sep 8, 2015·Chemical Communications : Chem Comm·Owen A DavisJames A Bull
May 31, 2017·Journal of Medicinal Chemistry·Markus FollmannJohannes-Peter Stasch
May 17, 2017·Angewandte Chemie·Alexander A KirichokPavel K Mykhailiuk
Jul 1, 2017·Angewandte Chemie·Alexander R WhiteChristopher D Vanderwal
Jan 18, 2018·Chemistry : a European Journal·Alexander A KirichokPavel K Mykhailiuk

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.